Citigroup’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.64M | Sell |
|
|||||
|
2023
Q3 | $6.87M | Buy |
|
|||||
|
2023
Q2 | $2.45M | Sell |
|
|||||
|
2023
Q1 | $5.91M | Buy |
|
|||||
|
2022
Q4 | $5.56M | Buy |
|
|||||
|
2022
Q3 | $5.53M | Sell |
|
|||||
|
2022
Q2 | $5.54M | Buy |
|
|||||
|
2022
Q1 | $1.69M | Sell |
|
|||||
|
2021
Q4 | $5.11M | Buy |
|
|||||
|
2021
Q3 | $3.29M | Sell |
|
|||||
|
2021
Q2 | $5.58M | Buy |
|
|||||
|
2021
Q1 | $5.05M | Sell |
|
|||||
|
2020
Q4 | $15.3M | Buy |
|
|||||
|
2020
Q3 | $1.47M | Sell |
|
|||||
|
2020
Q2 | $5.57M | Buy |
|
|||||
|
2020
Q1 | $2.73M | Buy |
|
|||||
|
2019
Q4 | $4.08M | Sell |
|
|||||
|
2019
Q3 | $3.56M | Sell |
|
|||||
|
2019
Q2 | $5.96M | Buy |
|
|||||
|
2019
Q1 | $609K | Sell |
|
|||||
|
2018
Q4 | $6.92M | Buy |
|
|||||
|
2018
Q3 | $2.82M | Buy |
|
|||||
|
2018
Q2 | $1.21M | Sell |
|
|||||
|
2018
Q1 | $818K | Sell |
|
|||||
|
2017
Q4 | $758K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $1K | Buy |
|
|||||
|
2016
Q4 | $1K | Buy |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $3K | Sell |
|
|||||
|
2016
Q1 | $269K | Buy |
|
|||||
|
2015
Q4 | $166K | Sell |
|
|||||
|
2015
Q3 | $11.8M | Buy |
|
|||||
|
2015
Q2 | $76K | Buy |
|
|||||
|
2015
Q1 | $13K | Sell |
|
|||||
|
2014
Q4 | $23K | Buy |
|
|||||
|
2014
Q3 | $4K | Buy |
|
|||||
|
2014
Q2 | $1K | Buy |
|
|||||
|
2014
Q1 | $1K | Buy |
|